Mylan Labs Gets Nod To Manufacture Remdesivir For COVID-19 Patients

The Drug Controller General of India (DCGI) has granted permission to Mylan laboratories to manufacture and market the anti-viral drug remdesivir for ''restricted emergency use'' on hospitalised...

from NDTV News - Special https://ift.tt/3gyo74L